The impact of hmg-coa reductase inhibitors use on the clinical outcomes in critically ill patients with covid-19: a multicenter, cohort study

HIGHLIGHTS

• who: Khalid Al Sulaiman from the University Hospital Leipzig, Germany have published the Article: The impact of HMG-CoA reductase inhibitors use on the clinical outcomes in critically ill patients with COVID-19: A multicenter, cohort study, in the Journal: (JOURNAL) of March/01,/2020
• what: This study demonstrated that statin therapy in ICU patients with COVID-19 was associated with reduced risks of 30-day and all-cause in-hospital mortality.
• how: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.